Friday, Mar 29, 2024 | Last Update : 10:56 AM IST

three-drug HIV regimen

Gilead's three-drug HIV regimen wins European panel approval

Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.

30 Apr 2018 9:57 AM

ADVERTISEMENT
ADVERTISEMENT